Operating
Stock-Based Comp
STERIS Stock-Based Comp decreased by 25.9% to $15.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $15.30M to $15.70M. Over 3 years (FY 2022 to FY 2025), Stock-Based Comp shows relatively stable performance with a -0.2% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
Detailed definition
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Peer comparison
Standard across large-cap corporations; varies based on corporate compensation philosophy.
Metric ID:
stock_based_compensationHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.60M | $11.31M | $10.00M | $9.75M | $8.96M | $11.55M | $9.35M | $9.09M | $11.58M | $20.72M | $15.29M | $8.95M | $11.50M | $20.80M | $15.30M | $9.80M | $11.90M | $21.20M | $15.70M |
| QoQ Change | — | -57.5% | -11.6% | -2.5% | -8.1% | +28.8% | -19.1% | -2.7% | +27.3% | +78.9% | -26.2% | -41.5% | +28.5% | +80.9% | -26.4% | -36.0% | +21.5% | +78.2% | -25.9% |
| YoY Change | — | — | — | — | -66.3% | +2.1% | -6.5% | -6.7% | +29.2% | +79.4% | +63.6% | -1.6% | -0.7% | +0.4% | +0.0% | +9.5% | +3.5% | +1.9% | +2.6% |
Range$8.95M – $26.60M
CAGR-11.1%
Avg YoY Growth+7.4%
Median YoY Growth+1.9%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is STERIS's stock-based comp?
- STERIS (STE) reported stock-based comp of $15.70M in Q4 2025.
- How has STERIS's stock-based comp changed year-over-year?
- STERIS's stock-based comp increased by 2.6% year-over-year, from $15.30M to $15.70M.
- What is the long-term trend for STERIS's stock-based comp?
- Over 3 years (2022 to 2025), STERIS's stock-based comp has grown at a -0.2% compound annual growth rate (CAGR), from $57.66M to $57.40M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock instead of cash.